Program Details
Information about medical programs provided by each healthcare institution, including treatment details, schedules, and costs.
- 治療
- 免疫療法
Immune Checkpoint Inhibitor Therapy [Nakamura Gastroenterology Clinic]
Cancer cells have mechanisms that allow them to evade attacks by immune cells (T cells). Immune checkpoint inhibitors are drugs that block these mechanisms, making it easier for T cells to attack cancer cells.
These therapies are considered particularly effective for cancers in which the protein PD-L1 is highly expressed on tumor cells.
A PD-1 antibody (nivolumab), which binds to PD-L1, is primarily used.
PD-L1 expression can be evaluated through immunohistochemical staining using tumor tissue specimens.
Cancer cells have mechanisms that allow them to evade attacks by immune cells (T cells). Immune checkpoint inhibitors are drugs that block these mechanisms, making it easier for T cells to attack cancer cells.
These therapies are considered particularly effective for cancers in which the protein PD-L1 is highly expressed on tumor cells.
A PD-1 antibody (nivolumab), which binds to PD-L1, is primarily used.
PD-L1 expression can be evaluated through immunohistochemical staining using tumor tissue specimens.
Additional Information:
１．Possible side effects
Side effects such as arrhythmia, interstitial pneumonia, myasthenia gravis, diabetes, hepatitis, thyroid dysfunction, pituitary dysfunction, renal impairment, skin disorders, and allergic reactions may occur.
Therefore, blood tests, chest X-rays, electrocardiograms (ECG), and urine tests are performed before and after administration.
２．Administration
The infusion (intravenous drip) takes approximately one hour.
３．Combination therapy
This treatment can be used in combination with immunotherapy.
- Providing Medical Institution
-
Nakamura Gastroenterology Clinic
〒561-0832https://nakamura-icho.com/
2-22-8 Shonai Nishi-machi, Toyonaka City- Specialty
- Medical Oncology
Gastroenterology
Endoscopy (or Endoscopic Medicine)
- Remarks
- 【Indications / Conditions】 All types of cancer (excluding hematological malignancies)